TN-01
Brief description of study
Through participation in this study, UPenn will become a TrialNet Natural History Study affiliate site. TrialNet, (short title) began in 2004 and has screened over 240,000 family members for diabetes related antibodies. This specific Pathway to Prevention TrialNet study (TN-01) plans to perform baseline and repeat assessments over time in a population of adults (18+) in order to confirm immunologic status of individuals at risk for type 1 diabetes. The study is divided into a Screening and a Monitoring stage. Each stage will use a separate Informed Consent document for enrollment.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or